Contexium

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 28 Jan 2028. The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program in…

Opportunity overview

Project name
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the...

Frequently asked questions

What is Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)?

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 28 Jan 2028. The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program in…

Who is funding Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)?

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)?

The application deadline is 28 Jan 2028 00:00 (UTC).

Where will the Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) project take place?

The project location(s) are: United States.

How can I apply for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.